Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
CONCLUSIONS: The CP service was not directly cost-benefit at the hospital perspective, but it presented savings for forecast cost related to the occurrence of preventable morbidities, measuring a good cost-benefit for the PHS.
Source: Revista de Saude Publica - Category: International Medicine & Public Health Source Type: research
More News: Brain | International Medicine & Public Health | Neurology | Study | Teaching | Teaching Hospitals | Universities & Medical Training